Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy

Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy

Abstract PD-1/PD-L1 inhibitors have been used to treat gastric cancer, and PD-L1 expression has been identified as a biomarker for predicting the effectiveness of immunotherapy in the treatment of gastric cancer. However, PD-L1 expression prediction for immunotherapy response is inaccurate, and impr...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo-Ya Li, Hui-Ling Li, Fei-Er Zeng, Xuan-Yu Luan, Bi-Qing Liu, Zhi-Zhou Wang, Lan Zhang, Xian-Zhe Dong
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Gastric adenocarcinoma
PD-L1 co-expression genes
Prospective biomarkers
Adjuvant therapeutic targets
BATF2
Online Access:https://doi.org/10.1007/s12672-025-02515-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-02515-1

Similar Items